Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Marcellin

Showing results (81-90 of 212) with videos related to

Pageof 22
Sort By:
The Journal of Infectious Diseases|September 1, 1989
Presence of Loa loa microfilariae in ascitic fluidM L Hautekeete, G Pailoux, P Marcellin, et al.
Lancet (London, England)|March 2, 1991
Second generation (RIBA) test in diagnosis of chronic hepatitis CP Marcellin, M Martinot-Peignoux, N Boyer, et al.
Annales De Dermatologie Et De Venereologie|March 16, 2000
[Alpha interferon-induced eczema in atopic patients infected by hepatitis C virus: 4 case reports]L Berger, V Descamps, Y Marck, et al.
Journal of Internal Medicine|November 1, 1990
Retroperitoneal fibrosis after surgery for aortic aneurysm in a patient with periarteritis nodosa: successful treatment with corticosteroidsM L Hautekeete, G Babany, P Marcellin, et al.
Journal of Viral Hepatitis|September 11, 2004
Racial differences in responses to interferon-beta-1a in chronic hepatitis C unresponsive to interferon-alpha: a better response in Chinese patientsP-N Cheng, P Marcellin, B Bacon, et al.
Lancet (London, England)|September 28, 1991
Fatal exacerbation of chronic hepatitis B induced by recombinant alpha-interferonP Marcellin, J F Colin, N Boyer, et al.
Gut|December 17, 2008
Gene expression and hepatitis C virus infectionT Asselah, I Bièche, A Sabbagh, et al.
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine|August 5, 2000
[Discovery of a chronic HVC infection without seroconversion in a blood donor in France during 28 months]F Durand, B Danic, R Tardivel, et al.
Gut|May 13, 2003
Second infection with a different hepatitis C virus genotype in a intravenous drug user during interferon therapyT Asselah, D Vidaud, A Doloy, et al.
Journal of Viral Hepatitis|June 26, 2003
Clinical relevance of total HCV core antigen testing for hepatitis C monitoring and for predicting patients' response to therapyM Maynard, P Pradat, P Berthillon, et al.
Pageof 22

Showing results (81-90 of 212) with videos related to

Sort By:
Pageof 22
The Journal of Infectious Diseases|September 1, 1989
Presence of Loa loa microfilariae in ascitic fluidM L Hautekeete, G Pailoux, P Marcellin, et al.
Lancet (London, England)|March 2, 1991
Second generation (RIBA) test in diagnosis of chronic hepatitis CP Marcellin, M Martinot-Peignoux, N Boyer, et al.
Annales De Dermatologie Et De Venereologie|March 16, 2000
[Alpha interferon-induced eczema in atopic patients infected by hepatitis C virus: 4 case reports]L Berger, V Descamps, Y Marck, et al.
Journal of Internal Medicine|November 1, 1990
Retroperitoneal fibrosis after surgery for aortic aneurysm in a patient with periarteritis nodosa: successful treatment with corticosteroidsM L Hautekeete, G Babany, P Marcellin, et al.
Journal of Viral Hepatitis|September 11, 2004
Racial differences in responses to interferon-beta-1a in chronic hepatitis C unresponsive to interferon-alpha: a better response in Chinese patientsP-N Cheng, P Marcellin, B Bacon, et al.
Lancet (London, England)|September 28, 1991
Fatal exacerbation of chronic hepatitis B induced by recombinant alpha-interferonP Marcellin, J F Colin, N Boyer, et al.
Gut|December 17, 2008
Gene expression and hepatitis C virus infectionT Asselah, I Bièche, A Sabbagh, et al.
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine|August 5, 2000
[Discovery of a chronic HVC infection without seroconversion in a blood donor in France during 28 months]F Durand, B Danic, R Tardivel, et al.
Gut|May 13, 2003
Second infection with a different hepatitis C virus genotype in a intravenous drug user during interferon therapyT Asselah, D Vidaud, A Doloy, et al.
Journal of Viral Hepatitis|June 26, 2003
Clinical relevance of total HCV core antigen testing for hepatitis C monitoring and for predicting patients' response to therapyM Maynard, P Pradat, P Berthillon, et al.
Pageof 22